fda cleared semaglutide immunoassay detection ELISA Kit | Ozempic WegovyQuantification Multifactor Quality and Safety Analysis

#ObesityManagement #GLP1 #Endocrinology #Pharmacology #FDAApproval #WeightLoss #IncretinTherapy #ClinicalUpdates #HealthcareInnovation MBBS, MD, FICD, CCIGC | Physician & Medical Educator | Founder of @dr.pharmaxx94 (16k+ Instagram | 3K+ LinkedIn community) | Evidence-based medicine & public health communication Major FDA Approval (April 2026): A Turning Point in Obesity Management The Orforglipron has been approved by the U.S

Weight regain is more likely without a maintenance plan in place, but factors like protein intake, strength training, sleep, stress management, and gradual tapering can significantly reduce the amount of weight regained

This article breaks all of that down in detail

Abstract Background This study aimed to assess the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and interest in using medications for weight loss among adults ( 18 years) in Great Britain